-
Allergic rhinitis affects 10%-20% of the population, and it greatly affects quality of life.
-
-
Results of this randomized clinical trial strongly suggest that Medical Qigong (MQ) can help people with cancer improve their quality of life (QOL) and lessen specific cancer- or treatment-related symptoms. The authors propose that MQ works in part by attending to the emotional and psychological well-being of the patient in addition to their physical health. Lack of a placebo sham group and high dropout rates negatively influence confidence in the authors' conclusions.
-
Iyengar yoga training and practice was shown by the authors to significantly improve functional disability, pain, and depression in adults with chronic low back pain, compared to a control group receiving standard medical care. The yoga group also demonstrated a trend to reduce pain medicine use compared to the control group.
-
Addressing the accumulating evidence for pomegranate's effects on various cardiovascular parameters, this study explored the impact of 240 mL of pomegranate juice daily for 18 months on carotid intima-media thickness (CIMT), a known risk factor for stroke and myocardial infarction. The results failed to show a difference in CIMT or antioxidant parameters (the proposed mechanism), except for subgroup analyses on people at particularly high risk for cardiovascular disease.
-
In this randomized clinical trial, patients with newly diagnosed type 2 diabetes assigned to a Mediterranean-style diet had better glycemic control and were less likely to need oral antihyperglycemic drug therapy than patients assigned to a low-fat diet.
-
-
The ECG shown above was obtained from a 60-year-old man with a history of a dilated cardiomyopathy. Given this information, what clinical concerns might you have if this patient presented to the emergency department in heart failure with the tracing above?
-
A monoclonal antibody against interleukin-12 and interleukin-23 has been approved by the FDA for the treatment of plaque psoriasis. Ustekinumab is marketed as a subcutaneous injection by Centocor Ortho Biotech as Stelara™.
-
Data early on in the pandemic influenza outbreak suggested that most severely ill patients with influenza A were not suffering from bacterial co-infection.